From: APOE effects on regional tau in preclinical Alzheimer’s disease
Full Dataset | Tau Subset | |||
---|---|---|---|---|
Aβ- (n = 3163) | Aβ+ (n = 1323) | Aβ- (n = 55) | Aβ+ (n = 392) | |
Age, mean (SD) | 71.0 (4.5) | 72.1 (4.9) | 69.7 (4.3) | 72.1 (4.8) |
Sex, n (%) | ||||
Male | 1278 (40%) | 545 (41%) | 23 (42%) | 167 (43%) |
Female | 1885 (60%) | 778 (59%) | 32 (58%) | 225 (57%) |
APOE genotype, n (%) | ||||
e2/e2 | 23 (1%) | 2 (0%) | 0 (0%) | 1 (0%) |
e2/e3 | 380 (12%) | 69 (5%) | 4 (7%) | 17 (4%) |
e2/e4 | 74 (2%) | 42 (3%) | 1 (2%) | 13 (3%) |
e3/e3 | 1936 (61%) | 481 (36%) | 37 (67%) | 147 (38%) |
e3/e4 | 684 (22%) | 611 (46%) | 13 (24%) | 182 (46%) |
e4/e4 | 34 (1%) | 105 (8%) | 0 (0%) | 25 (6%) |
Missing | 32 (1%) | 13 (1%) | 0 (0%) | 7 (2%) |
Amyloid Centiloid, mean (SD) | – | – | 4.0 (9.9) | 54.8 (30.3) |